PHVSPharvaris N.V.vs its industry peers
A metric-by-metric comparison of Pharvaris N.V. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PHVSThis | $2.2B#3 | — | — | — | — | — | — | — | — | — | 57.4%#1 | — |
| OTLC | — | — | — | — | — | 5610.7%#1 | -4552.3%#8 | 94.2%#1 | -0.8%#2 | — | — | — |
| OWPC | — | — | — | — | -35.9%#8 | 0.5%#9 | -38494.6%#10 | — | — | 5#1 | — | — |
| PAHC | — | 16.1x#1 | — | — | 17.1%#5 | 106.6%#3 | 12.8%#1 | 25.9%#2 | 14.8%#1 | — | -7.0%#3 | — |
| PBM | $8M#5 | — | — | — | — | 102.0%#4 | — | — | — | — | -82.5%#7 | — |
| PBMWW | $27749#8 | — | — | — | — | 102.0%#4 | — | — | — | — | -51.6%#5 | — |
| PCYN | — | — | — | — | 6.4%#6 | -579.0%#12 | -4.6%#3 | -14.9%#3 | -10.5%#3 | — | — | — |
| PHAR | $8.5B#1 | — | — | 22.6x#3 | 26.6%#4 | 124.1%#2 | 6.9%#2 | — | — | — | -10.9%#4 | — |
| PKTX | — | — | — | — | — | -8.1%#10 | — | -132.1%#7 | — | — | — | — |
| PMHS | — | — | — | — | 1002.0%#1 | -697.8%#13 | -1627.5%#6 | — | — | — | — | — |
| PPBT | $2.2B#2 | — | 231.6x#4 | 2249.3x#5 | 0.0%#7 | -264.4%#11 | -2227.1%#7 | -271.6%#8 | — | — | -86.0%#8 | — |
| PRE | $272M#4 | — | 1.6x#3 | 8.9x#2 | 40.8%#2 | 26.2%#7 | -157.2%#4 | -27.2%#4 | — | — | 24.1%#2 | — |
| PRENW | $187302#7 | — | 0.0x#1 | 0.0x#1 | 40.8%#2 | 26.2%#7 | -157.2%#4 | -27.2%#4 | — | — | -53.8%#6 | — |
| PRFX | $582426#6 | — | 0.1x#2 | 34.3x#4 | — | 65.6%#6 | -30129.4%#9 | -58.8%#6 | — | — | -86.8%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice